Skip to content
IPX066145

Drawing based on the label description. No photo yet.

“Carbidopa and Levodopa Extended-release Capsules, 36.25 mg/145 mg: blue and light blue capsule imprinted with IPX066 on the capsule cap and 145 on the capsule body”

IPX066 145 pill

Pill with imprint IPX066 145 is blue, capsule, 19 mm and has been identified as Carbidopa and Levodopa 36.25 mg / 145 mg. It is used for Parkinson's disease. It is supplied by Zydus Pharmaceuticals USA Inc.

Carbidopa and Levodopa 36.25 mg / 145 mg

Imprint
IPX066 145
Strength
Carbidopa Anhydrous 36.25 mg / Levodopa 145 mg
Used for
Parkinson's disease
Color
Blue
Shape
Capsule / oblong
Size
19 mm
Score
No score line
Form
Capsule, extended release
Manufacturer
Zydus Pharmaceuticals USA Inc
Drug class
Parkinson's medicine
NDC
70710-2140, 70710-2140-1, 70518-4630, 70518-4630-1, 70518-4630-0

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Carbidopa and Levodopa pills and guides

What is Carbidopa and Levodopa used for?

Carbidopa and Levodopa is used for Parkinson's disease.

Medicine type
Parkinson's medicine; aromatic amino acid
Official uses from the US prescribing label

Carbidopa and levodopa tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.

Carbidopa allows patients treated for Parkinson's disease to use much lower doses of levodopa. Some patients who responded poorly to levodopa have improved on carbidopa and levodopa tablets. This is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. Carbidopa has not been shown to enhance the intrinsic efficacy of levodopa.

Carbidopa may also reduce nausea and vomiting and permit more rapid titration of levodopa.

From the FDA-approved label on DailyMed (published Sep 28, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows IPX066 145. The parts can be split between the two sides, so turn the pill over and check both.
  • It is blue, capsule, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Carbidopa, Levodopa

Inactive: Alcohol, Ammonia, Butyl Alcohol, Croscarmellose Sodium, Ethylcellulose, Fd&c Blue No. 2, Ferric Oxide Yellow, Gelatin, Hypromellose 2910 (6 Mpa.s), Isopropyl Alcohol, Magnesium Stearate, Mannitol, Methacrylic Acid - Methyl Methacrylate Copolymer (1:1), Methacrylic Acid - Methyl Methacrylate Copolymer (1:2), Microcrystalline Cellulose, Povidone, Propylene Glycol, Shellac, Sodium Lauryl Sulfate, Sodium Starch Glycolate Type A Potato, Talc, Tartaric Acid, Titanium Dioxide, Triethyl Citrate

Also distributed by

Remedyrepack Inc.

Other pills with imprint IPX066 145

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Carbidopa and Levodopa pills